Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
Public ClinicalTrials.gov record NCT07610837. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIa, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZD2389 in Adult Participants With Steatotic Liver Disease and Advanced Fibrosis (BRAVO)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety, tolerability, and pharmacodynamic effects of AZD2389 in adult participants with steatotic liver disease (SLD) and advanced fibrosis.
Study identification
- NCT ID
- NCT07610837
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 104 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 6, 2026
- Primary completion
- Jul 6, 2027
- Completion
- Jul 6, 2027
- Last update posted
- Aug 31, 2026
2026 – 2027
United States locations
- U.S. sites
- 20
- U.S. states
- 9
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Chandler | Arizona | 85224 | Recruiting |
| Research Site | Tucson | Arizona | 85712 | Recruiting |
| Research Site | Jupiter | Florida | 33458 | Recruiting |
| Research Site | Miami | Florida | 33122 | Recruiting |
| Research Site | Port Orange | Florida | 32127 | Recruiting |
| Research Site | Kansas City | Missouri | 64131 | Recruiting |
| Research Site | St Louis | Missouri | 63123 | Recruiting |
| Research Site | Las Vegas | Nevada | 89106 | Recruiting |
| Research Site | Morehead City | North Carolina | 28557 | Recruiting |
| Research Site | Raleigh | North Carolina | 27607 | Recruiting |
| Research Site | Westlake | Ohio | 44145 | Recruiting |
| Research Site | Yukon | Oklahoma | 73099 | Recruiting |
| Research Site | Clarksville | Tennessee | 37040 | Recruiting |
| Research Site | Austin | Texas | 78757 | Recruiting |
| Research Site | Denison | Texas | 75020 | Recruiting |
| Research Site | Georgetown | Texas | 78626 | Recruiting |
| Research Site | Houston | Texas | 77004 | Recruiting |
| Research Site | Houston | Texas | 77079 | Recruiting |
| Research Site | San Antonio | Texas | 78215 | Recruiting |
| Research Site | San Antonio | Texas | 78222 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Liver Fibrosis trials
Other public records listing Liver Fibrosis. Sorted by last update posted; newest first. Not a recommendation.
- NCT07730853: Isocaloric Navy-Bean Substitution in Adults With MASLD Not yet recruiting
- NCT06632444: LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis Recruiting
- NCT05526144: Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans Recruiting
- NCT06138821: Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial Recruiting
- NCT06374875: Fibrosis Lessens After Metabolic Surgery Recruiting
- NCT07122700: Evaluation of Non-Invasive Tests for Metabolic Liver Disease Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07610837, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 31, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07610837 live on ClinicalTrials.gov.